Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin Treatment
S. Matthijs Boekholdt(Amsterdam Neuroscience), J Kastelein(University of Amsterdam), Philippa J. Talmud(University College London), Jan Albert Kuivenhoven(University Medical Center Groningen), Heikki Kauma(University of Oulu), Viviane Nicaud(Inserm), Frank M. Sacks(Harvard University), Markku J. Savolainen(Leiden University Medical Center), J. Shepherd(University of Glasgow), Aeilko H. Zwinderman(Amsterdam Neuroscience), Sakari Kakko(Leiden University Medical Center), Guðný Eiríksdóttir(Icelandic Heart Association), Greetje J. de Grooth(Radboud University Nijmegen), Steve E. Humphries(University College London), Marcello Arca(Sapienza University of Rome), Dilys J. Freeman(Leiden University Medical Center), Simin Liu(Hunan University of Technology), Anna Montali(Leiden University Medical Center), George J. Miller(Leiden University Medical Center), Alex D. McMahon(Leiden University Medical Center), François Cambien(Inserm), Vilmundur Guðnason(University of Iceland), Hans Lanz(Leiden University Medical Center), J. Wouter Jukema(Leiden University Medical Center)
Cited by 310
Related Papers
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in Women
|New England Journal of Medicine|2001|2.9k